This webinar will include a detailed discussion of Contract Manufacturing Organizations (CMO) Quality Agreement topics such as change control, documentation, facilities and equipment, lab controls, ...

Samsung Biologics announced on Jan. 14 that it has secured a 2.07 trillion won ($1.41 billion) contract, marking the largest ...

Samsung Biologics, the country’s leading pharmaceutical contract manufacturing organization (CMO), announced Tuesday it has ...

The rise in Senores Pharmaceuticals share came after the company's strong show in the December quarter (Q3FY25) results ...

Drug Substance manufacturing is a critical component of pharmaceutical production, requiring precise processes, rigorous quality control, and innovative solutions to overcome various challenges ...

Samsung Biologics signs record 2 trillion won contract, strengthens global position Samsung Biologics achieves historic ...

The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology ...

Samsung Biologics announced on the 17th that it has signed a contract for contract manufacturing organization (CMO) with a U.S. pharmaceutical company. The contract size is 111.2 billion won ...

Manufacturing problems ... any additional clinical trials of the drug. That suggests the delay could be relatively short, assuming the issues at the CMO can be resolved in a timely manner or ...